Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Agnelli G, Gussoni G, Bianchini C et al (2009) Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. Lancet Oncol 10:943–949
2. Austrian Outpatient Self-Payers Guide 2015. Available at ( https://www.ris.bka.gv.at/defaultEn.aspx ). Accessed 10 December 2015.
3. Avritscher EB, Shih YC, Sun CC et al (2010) Cost-utility analysis of palonosetron-based therapy in preventing emesis among breast cancer patients. J Support Oncol 8:242–251
4. Blom JW, Vanderschoot JP, Oostindiër MJ et al (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4:529–535
5. Canadian Agency for Drugs and Technology in Health. Guidelines for the Economic Evaluation of Health Technologies. Ottawa, Canada, 3rd Edition, 2006 ( http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf ). Accessed 18 August 2015.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献